Literature DB >> 19212732

[Autoimmune pancreatitis].

A Schneider1, J M Löhr.   

Abstract

Autoimmune pancreatitis has been established as a special entity of pancreatitis. It is an enigmatic disease since it is adding an autoimmune etiology to the existing causes of pancreatitis. Morphological hallmarks of the disease are narrowing of the pancreatic duct system and the bile duct by periductal lymphoplasmocytic inflammation. This results in many cases in obstructive jaundice due to a mass-forming lesion in the pancreatic head mimicking pancreatic ductal adenocarcinoma. Therefore, patients will frequently undergo surgery. Histopathologically, the disease can be diagnosed by IgG4-positive plasma cells. Serologically, patients may present with elevated serum IgG and IgG4 levels. Other autoantibodies are also described. Association with other autoimmune manifestations in a wide range of organs is frequent. Autoimmune pancreatitis will respond to steroid treatment, which is of specific importance because pancreatic cancer is one of its clinical differential diagnoses. It is important to positively diagnose autoimmune pancreatitis, especially if the bile ducts are affected, since cholangitis may be or become a prominent problem before or after surgery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19212732     DOI: 10.1007/s00108-008-2262-1

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  121 in total

1.  Helicobacter pylori in colorectal carcinoma tissue.

Authors:  Milutin Bulajic; Bojan Stimec; Ralf Jesenofsky; Dragutin Kecmanovic; Miljan Ceranic; Nada Kostic; Wulf Schneider-Brachert; Albert Lowenfels; Patrick Maisonneuve; Johannes-Matthias Löhr
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-03       Impact factor: 4.254

Review 2.  Autoimmune polyglandular syndromes.

Authors:  P Obermayer-Straub; M P Manns
Journal:  Baillieres Clin Gastroenterol       Date:  1998-06

Review 3.  Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis.

Authors:  K Yoshida; F Toki; T Takeuchi; S Watanabe; K Shiratori; N Hayashi
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

4.  Immortalization of pancreatic stellate cells as an in vitro model of pancreatic fibrosis: deactivation is induced by matrigel and N-acetylcysteine.

Authors:  Ralf Jesnowski; Daniel Fürst; Jörg Ringel; Ying Chen; Andrea Schrödel; Jörg Kleeff; Armin Kolb; Wolfgang D Schareck; Matthias Löhr
Journal:  Lab Invest       Date:  2005-10       Impact factor: 5.662

5.  Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis.

Authors:  Takahiro Nakazawa; Hirotaka Ohara; Hitoshi Sano; Shigeru Aoki; Shinya Kobayashi; Tetsu Okamoto; Hideto Imai; Tomoyuki Nomura; Takashi Joh; Makoto Itoh
Journal:  Gastrointest Endosc       Date:  2004-12       Impact factor: 9.427

Review 6.  Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease.

Authors:  Terumi Kamisawa; Atsutake Okamoto
Journal:  J Gastroenterol       Date:  2006-07       Impact factor: 7.527

7.  IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis?

Authors:  Yoh Zen; Kenichi Harada; Motoko Sasaki; Yasunori Sato; Koichi Tsuneyama; Joji Haratake; Hiroshi Kurumaya; Kazuyoshi Katayanagi; Shinji Masuda; Hideki Niwa; Hideo Morimoto; Atsuo Miwa; Akio Uchiyama; Bernard C Portmann; Yasuni Nakanuma
Journal:  Am J Surg Pathol       Date:  2004-09       Impact factor: 6.394

8.  Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study.

Authors:  Estrid Muff Munk; Lars Pedersen; Andrea Floyd; Bente Nørgård; Henrik Højgaard Rasmussen; Henrik T Sørensen
Journal:  Am J Gastroenterol       Date:  2004-05       Impact factor: 10.864

9.  Sclerosing cholangitis associated with autoimmune pancreatitis.

Authors:  Shigeyuki Kawa; Hideaki Hamano; Takeji Umemura; Kendo Kiyosawa; Takeshi Uehara
Journal:  Hepatol Res       Date:  2007-10       Impact factor: 4.288

10.  Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjögren's syndrome.

Authors:  J Kino-Ohsaki; I Nishimori; M Morita; K Okazaki; Y Yamamoto; S Onishi; M A Hollingsworth
Journal:  Gastroenterology       Date:  1996-05       Impact factor: 22.682

View more
  6 in total

1.  Autoimmune Pancreatitis and IgG4-Related Disease: The Storiform Discovery to Treatment.

Authors:  Kazuichi Okazaki
Journal:  Dig Dis Sci       Date:  2019-09       Impact factor: 3.199

Review 2.  Autoimmune pancreatitis: Multimodality non-invasive imaging diagnosis.

Authors:  Stefano Crosara; Mirko D'Onofrio; Riccardo De Robertis; Emanuele Demozzi; Stefano Canestrini; Giulia Zamboni; Roberto Pozzi Mucelli
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 3.  Current concept and diagnosis of IgG4-related disease in the hepato-bilio-pancreatic system.

Authors:  Kazuichi Okazaki; Kazushige Uchida; Tsukasa Ikeura; Makoto Takaoka
Journal:  J Gastroenterol       Date:  2013-02-16       Impact factor: 7.527

Review 4.  From Pathogenesis, Clinical Manifestation, and Diagnosis to Treatment: An Overview on Autoimmune Pancreatitis.

Authors:  Ou Cai; Shiyun Tan
Journal:  Gastroenterol Res Pract       Date:  2017-01-19       Impact factor: 2.260

5.  Autoimmune pancreatitis: Imaging features.

Authors:  Yi Dong; Mirko D'Onofrio; Michael Hocke; Christian Jenssen; Andrej Potthoff; Nathan Atkinson; Andre Ignee; Christoph F Dietrich
Journal:  Endosc Ultrasound       Date:  2018 May-Jun       Impact factor: 5.628

Review 6.  Focal Autoimmune Pancreatitis: A Simple Flow Chart for a Challenging Diagnosis.

Authors:  Clara Benedetta Conti; Fabrizio Cereatti; Andrea Drago; Roberto Grassia
Journal:  Ultrasound Int Open       Date:  2021-01-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.